Isofol Medical AB (publ)
556759-8064ActiveDeveloping next-generation folate drug to improve cancer treatment efficacy.
Oversikt
- 10–19
- Ansatte
- ≤1t SEK
- Omsetning
- 2008
- Grunnlagt
Beskrivelse
Isofol is a publicly listed biotechnology company focused on advancing cancer care. The organization is dedicated to developing its drug candidate, arfolitixorin, a novel folate-based therapy. Arfolitixorin is specifically designed to enhance the efficacy of standard first-line treatments for severe...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556759806401
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
NUCLITHERA AS
9 ansatteDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Exocure Sweden AB
Exocure pioneers exosome biotechnology for advanced cancer therapeutics.
Ambusol AB (publ)
1–4 ansattePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
BioGaia Pharma AB
0 ansatteDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Medivir Aktiebolag
10–19 ansatteDeveloping transformative pharmaceutical treatments for unmet cancer needs.
Utforsk mer
Spørsmål om Isofol Medical AB (publ)
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo